Adult T-cell Leukemia/Lymphoma

23 clinical trials · Condition

Record	Firm	Date
Two Step Haplo With Radiation Conditioning (NCT05031897)	Thomas Jefferson University	2021-10-25
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) (NCT04301076)	National Cancer Institute (NCI)	2021-08-31
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) (NCT04703192)	Daiichi Sankyo	2021-06-03
Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma (NCT04102150)	Daiichi Sankyo Co., Ltd.	2019-11-21
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma (NCT03264131)	UNC Lineberger Comprehensive Cancer Center	2018-10-11
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma (NCT03113500)	City of Hope Medical Center	2017-05-25
Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma (NCT02631746)	National Cancer Institute (NCI)	2017-02-23
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma (NCT02737046)	University of Miami	2016-12-12
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) (NCT02588651)	Deepa Jagadeesh	2016-06-17
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715)	Mayo Clinic	2016-01-19
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma (NCT01724177)	Celgene	2012-11-12
KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) (NCT01626664)	Kyowa Kirin, Inc.	2012-06-01
Lenalidomide in HTLV-1 Adult T-Cell Leukemia (NCT01274533)	Columbia University	2010-12-01
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy (NCT01184885)	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	2010-07-01
A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma (NCT01169298)	Celgene	2010-07-01
Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma (NCT00920790)	Kyowa Kirin Co., Ltd.	2009-06-01

Track Adult T-cell Leukemia/Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.